What Evommune, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 2 | 7 |
| Sells | 3 | 9 |
| Total trades | 8 | 49 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 32,488 | 20,953,668 |
| Disposed | 28,926 | 169,971 |
| Net activity | +3,562 | +20,783,697 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Carver Kyle | Chief Financial Officer | Jul 08 | Open-market buy · P | +1,000 | $13.26 | +$13.3K | 60,335 |
| Kirsch Arthur S | Director | Jul 07 | Open-market buy · P | +10,000 | $13.30 | +$133K | 10,000 |
| Pena Luis C. | President & CEO | Jun 22 | Open-market sale · S | −7,438 | $22.71 | −$169K | 630,458 |
| Drew Janice Suzann | Chief of Dev. Operations | Jun 22 | Open-market sale · S | −20,000 | $22.63 | −$453K | 67,794 |
| Drew Janice Suzann | Chief of Dev. Operations | Jun 22 | Exercise / conversion · M | +16,161 | $2.99 | +$48.3K | 87,794 |
| Drew Janice Suzann | Chief of Dev. Operations | Jun 22 | Exercise / conversion · M | +3,839 | $3.84 | +$14.7K | 71,633 |
| Patel Jeegar Pravinkumar | Chief Scientific Officer | Jun 22 | Open-market sale · S | −1,488 | $22.50 | −$33.5K | 46,403 |
| Patel Jeegar Pravinkumar | Chief Scientific Officer | Jun 22 | Exercise / conversion · M | +1,488 | $3.84 | +$5.71K | 47,891 |
| Cohen David E | Director | Jun 02 | Open-market sale · S | −600 | $21.38 | −$12.8K | 17,609 |
| Cohen David E | Director | Jun 02 | Open-market sale · S | −5,456 | $20.21 | −$110K | 18,209 |
| Pena Luis C. | President & CEO | Jun 01 | Open-market sale · S | −16,787 | $22.74 | −$382K | 637,896 |
| Patel Jeegar Pravinkumar | Chief Scientific Officer | Jun 01 | Open-market sale · S | −16,687 | $22.74 | −$379K | 46,403 |
| Patel Jeegar Pravinkumar | Chief Scientific Officer | Jun 01 | Exercise / conversion · M | +13,512 | $3.84 | +$51.9K | 63,090 |
| Moss Gregory S. | Chief Business & Legal Officer | May 28 | Open-market sale · S | −14,223 | $22.83 | −$325K | 60,835 |
| Moss Gregory S. | Chief Business & Legal Officer | May 28 | Exercise / conversion · M | +14,223 | $1.71 | +$24.3K | 75,058 |
| Carver Kyle | Chief Financial Officer | May 28 | Open-market sale · S | −18,175 | $22.84 | −$415K | 59,335 |
| Carver Kyle | Chief Financial Officer | May 28 | Exercise / conversion · M | +15,000 | $2.99 | +$44.9K | 77,510 |
| Ra Capital MANAGEMENT, L.p. | Director | Feb 17 | Grant / award · A | +35,868 | $27.88 | +$1M | 2,710,293 |
| Verduyn-van Weegen Felice Isabel | Director | Feb 17 | Grant / award · A | +358,680 | $27.88 | +$10M | 5,288,313 |
| Lsp 7 Cooperative Ua | Director | Feb 17 | Grant / award · A | +358,680 | $27.88 | +$10M | 5,288,313 |
Loading...